Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daprodustat in heart failure patients with renal anemia
jRCT1051210196Completed
- Start
- Oct 2022
- Countries
- 1
01
Overview
Randomised trial in anemia of renal disease (2 arms). Primary endpoint: Hemoglobin level at 16 weeks after randomization. Started Oct 2022; status: completed.
02
Conditions
anemia of renal disease
Beyond the preview
Go deeper on jRCT1051210196.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1051210196.